NCT03072784 is a NA clinical trial of aortic cross clamping in Bypass Complication, sponsored by Assiut University.

Who is sponsoring NCT03072784?

NCT03072784 is sponsored by Assiut University.

What drugs are being tested in NCT03072784?

Interventions in NCT03072784: aortic cross clamping.

What condition does NCT03072784 study?

NCT03072784 studies Bypass Complication, Respiratory Complication.

Is NCT03072784 still recruiting?

NCT03072784 is currently completed. Last updated 9 March 2017.

Last reviewed 2017-03-09 · How we verify

NCT03072784

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Aortic Cross Clamping Time, and Postoperative Respiratory Function

Completed NA Last updated 9 March 2017

What this trial tests

NA trial testing aortic cross clamping in Bypass Complication in 53 participants. Completed in 25 August 2016.

Timeline

1 February 2015

Primary endpoint
20 April 2016

25 August 2016

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	double
Primary purpose	other
Enrollment	53
Start date	1 February 2015
Primary completion	20 April 2016
Estimated completion	25 August 2016
Sites	1 location across Egypt

Drugs / interventions tested

aortic cross clamping

Conditions studied

Bypass Complication — all drugs for Bypass Complication →
Respiratory Complication — all drugs for Respiratory Complication →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Bypass Complication or Respiratory Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Does the duration of cardiopulmonary bypass, and aortic cross clamping affects the post operative pulmonary function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03072784 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 9 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03072784.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing